TY - JOUR
T1 - What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients?
AU - Andrisani, Gianluca
AU - Armuzzi, Alessandro
AU - Marzo, Manuela
AU - Felice, Carla
AU - Pugliese, Daniela
AU - Papa, Alfredo
AU - Guidi, Luisa
PY - 2016
Y1 - 2016
N2 - The use of biological agents and immunomodulators for inflammatory bowel disease (IBD) is associated with an increased risk of opportunistic infections, in particular of viral or bacterial etiology. Despite the existence of international guidelines, many gastroenterologists have not adopted routine screening and vaccination in those patients with IBD, which are candidate for biologic therapy. Available strategies to screen, diagnose and prevent bacterial and viral infections in patients with IBD prior to start biological therapy are discussed in this review
AB - The use of biological agents and immunomodulators for inflammatory bowel disease (IBD) is associated with an increased risk of opportunistic infections, in particular of viral or bacterial etiology. Despite the existence of international guidelines, many gastroenterologists have not adopted routine screening and vaccination in those patients with IBD, which are candidate for biologic therapy. Available strategies to screen, diagnose and prevent bacterial and viral infections in patients with IBD prior to start biological therapy are discussed in this review
KW - Anti-tumor necrosis factor agents
KW - Corticosteroids
KW - Immunomodulators
KW - Inflammatory bowel disease
KW - Opportunistic infections
KW - Anti-tumor necrosis factor agents
KW - Corticosteroids
KW - Immunomodulators
KW - Inflammatory bowel disease
KW - Opportunistic infections
UR - http://hdl.handle.net/10807/93029
U2 - 10.4292/wjgpt.v7.i3.387
DO - 10.4292/wjgpt.v7.i3.387
M3 - Article
SN - 2150-5349
VL - 7
SP - 387
EP - 396
JO - WORLD JOURNAL OF GASTROINTESTINAL PHARMACOLOGY AND THERAPEUTICS
JF - WORLD JOURNAL OF GASTROINTESTINAL PHARMACOLOGY AND THERAPEUTICS
ER -
